Health
Will Moderna Get Away With Charging 50% More Than Pfizer for Its Coronavirus Vaccine? – Motley Fool
Don’t be surprised it it does.
We now have a pretty good idea how much COVID-19 vaccines will cost Uncle Sam. Last week, The U.S. government announced a deal with Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) to buy 100 million doses of the two partners’ lead coronavirus vaccine candidate for $1.95 billion. That translates to a price tag of $19.50 per dose.
But Moderna(NASDAQ:MRNA) is considering pricing its COVID-19 vaccine at more than 50% higher than Pfizer’s price tag for its vaccine, according to a report in the Financial …
-
Business24 hours agoThese ASX 200 shares could rise 50% to 60%
-
General23 hours agoAustralia’s Myanmar community mourns earthquake losses
-
General22 hours agoPeter Dutton partially walks back public service work-from-home vow
-
Noosa News20 hours agoDisaster relief packages announced for flood-stricken western Queensland